Showing results (161-170 of 339) with videos related to

Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical TargetsFlorian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Cancers|February 16, 2020
The Impact of Cand1 in Prostate CancerAndrea Eigentler, Piotr Tymoszuk, Johanna Zwick, et al.
Haematologica|February 9, 2019
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experienceRon Ram, Christof Scheid, Odelia Amit, et al.
Journal of Hepatology|November 29, 2005
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in miceAnna Maria Wolf, Dominik Wolf, Matias A Avila, et al.
Cancers|August 23, 2020
The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior PrognosisNormann Steiner, Karin Jöhrer, Selina Plewan, et al.
Plos One|June 14, 2013
The role of the e3 ligase cbl-B in murine dendritic cellsStephanie Wallner, Christina Lutz-Nicoladoni, Christoph H Tripp, et al.
Annals of Hematology|December 3, 2016
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AMLUdo Holtick, Marco Herling, Natali Pflug, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 11, 2020
Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS)Julian Dominik Wolf, Markus Kurpiers, Roman Xaver Götz, et al.
Oncoscience|May 27, 2016
High prevalence of side population in human cancer cell linesMaximilian Boesch, Alain G Zeimet, Heidi Fiegl, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Pageof 34